This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004;24(3):333-6.

doi: 10.1385/JMN:24:3:333.

Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection

PMID: 15655257
DOI: 10.1385/JMN:24:3:333

Editorial

Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection

Illana Gozes. J Mol Neurosci. 2004.

. 2004;24(3):333-6.

doi: 10.1385/JMN:24:3:333.

Author

PMID: 15655257
DOI: 10.1385/JMN:24:3:333

No abstract available

PubMed Disclaimer

Similar articles

6th International Conference on Alzheimer's Disease and Parkinson's Disease.
Lahiri DK. Lahiri DK. Expert Opin Investig Drugs. 2003 Aug;12(8):1433-40. doi: 10.1517/13543784.12.8.1433. Expert Opin Investig Drugs. 2003. PMID: 12882629 No abstract available.
Protein degradation in Alzheimer's disease and aging of the brain.
Tsuji T, Shimohama S. Tsuji T, et al. Prog Mol Subcell Biol. 2002;29:43-60. doi: 10.1007/978-3-642-56373-7_4. Prog Mol Subcell Biol. 2002. PMID: 11908072 Review. No abstract available.
Molecules of the brain.
Levey AI. Levey AI. Hosp Pract (1995). 2000 Feb 15;35(2):41-8, 51-4. doi: 10.3810/hp.2000.02.186. Hosp Pract (1995). 2000. PMID: 10689389 Review.
Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.
Walsh DM, Selkoe DJ. Walsh DM, et al. Protein Pept Lett. 2004 Jun;11(3):213-28. doi: 10.2174/0929866043407174. Protein Pept Lett. 2004. PMID: 15182223 Review.
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.

See all similar articles

Cited by

Alterations of Nigral Dopamine Levels in Parkinson's Disease after Environmental Enrichment and PACAP Treatment in Aging Rats.
Jungling A, Reglodi D, Maasz G, Zrinyi Z, Schmidt J, Rivnyak A, Horvath G, Pirger Z, Tamas A. Jungling A, et al. Life (Basel). 2021 Jan 8;11(1):35. doi: 10.3390/life11010035. Life (Basel). 2021. PMID: 33429934 Free PMC article.
Establishment of stably transfected rat neuronal cell lines expressing alpha-synuclein GFP fusion proteins.
Schwach G, Tschemmernegg M, Pfragner R, Ingolic E, Schreiner E, Windisch M. Schwach G, et al. J Mol Neurosci. 2010 May;41(1):80-8. doi: 10.1007/s12031-009-9289-1. Epub 2009 Oct 9. J Mol Neurosci. 2010. PMID: 19816809

References

1. J Mol Neurosci. 2004;24(1):105-13 - PubMed
1. J Mol Neurosci. 2003;20(3):315-22 - PubMed
1. J Mol Neurosci. 2004;24(1):97-104 - PubMed
1. Brain Res. 2000 Jan 31;854(1-2):257-62 - PubMed
1. J Neurosci Res. 2003 Nov 1;74(3):342-52 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information